National Stock Number
6515-01-312-0372
National Stock Number (NSN) 6515-01-312-0372, or NIIN 013120372, (intravenous injection set) was assigned December 8, 1989 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, there are no suppliers listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 02, 1991, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 14415. [AN ITEM USED FOR ADMINISTERING INTRAVENOUS SOLUTION AND ADDITIVES IN CONTROLLED VOLUME FROM STANDARD SOLUTION BOTTLES OR BAGS. IT MAY BE USED WITH BLOOD FILTER UNIT FOR THE ADMINISTRATION OF BLOOD OR BLOOD DERIUATIVES. FOR ITEMS WHICH INCLUDE A BLOOD FILTER AS A COMPONENT, SEE BLOOD RECIPIENT SET, INDIRECT TRANSFUSION. FOR ITEMS WHICH INCLUDE A CASSETTE FOR INTRAVENOUS ADMINISTRATION, SEE CASSETTE-INTRAVENOUS INJECTION SET.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no data in the HMIRS and the NSN is in an FSC not generally suspected of containing hazardous materials. NSN 6515013120372 contains an unknown precious metal.
This NSN is associated to Schedule B 9018908000: other instruments and appliances used in medical, surgical, dental or veterinary sciences, nesoi. The Schedule B End Use is listed as medicinal equipment. NAICS classification category 339112: surgical and medical instrument manufacturing.
This information was last updated on Apr 01, 2024.